UK Markets closed

Ion Beam Applications SA (IOBCF)

Other OTC - Other OTC Delayed price. Currency in USD
Add to watchlist
11.130.00 (0.00%)
At close: 09:30AM EDT
Full screen
Trade prices are not sourced from all markets
Previous close11.13
Bid0.00 x 0
Ask0.00 x 0
Day's range11.13 - 11.13
52-week range11.13 - 23.21
Avg. volume223
Market cap329.902M
Beta (5Y monthly)0.52
PE ratio (TTM)6.91
Earnings dateN/A
Forward dividend & yield0.20 (1.17%)
Ex-dividend date29 Jun 2022
1y target estN/A
  • Globe Newswire

    IBA and SCK CEN launch Pantera, a joint-venture to produce actinium-225

    Louvain-La-Neuve, Belgium, 22 September 2022 – IBA (Ion Beam Applications S.A., EURONEXT), the world leader in particle accelerator technology, and the Belgian Nuclear Research Centre SCK CEN today announced the name of their joint-venture: Pantera SA/NV, which they believe will bring new hope for cancer patients. As indicated in the announcement of the R&D strategic partnership, this new company will aim to secure the large-scale production of actinium-225 (225Ac), one of the most promising alp

  • Globe Newswire

    NorthStar Medical Radioisotopes and IBA Sign Agreement for Two Additional Rhodotron® Electron Beam Accelerators for Commercial Production of Radioisotopes

    NorthStar is further expanding commercial-scale domestic radioisotope production capabilities using IBA’s environmentally preferable Rhodotron® accelerator technology Louvain-La-Neuve, Belgium, and BELOIT, Wisconsin, USA September 20, 2022 – IBA (Ion Beam Applications S.A., EURONEXT), the world leader in particle accelerator technology, and NorthStar Medical Radioisotopes, LLC, a global innovator in the development, production and commercialization of radiopharmaceuticals used for medical imagin

  • Globe Newswire

    IBA Reports Half Year 2022 Results

    RECORD ORDER INTAKE AND BACKLOG ACROSS THE GROUP HIGHLY ACTIVE PIPELINE FOR ALL BUSINESS LINES SOLID BALANCE SHEET WITH RECORD EUR 137 MILLION NET CASH Louvain-la-Neuve, Belgium, 31 August 2022 - IBA (Ion Beam Applications S.A), the world leader in particle accelerator technology, today announces its consolidated results for the first half of 2022. (EUR 000)H1 2022H1 2021VarianceVariance % Total Net Sales160 032137 18322 84916.7% Proton Therapy103 02670 47332 55346.2% Other Accelerators30 11040